Free Trial

agilon health (AGL) Competitors

agilon health logo
$3.90 -0.37 (-8.57%)
As of 01:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AGL vs. HIMS, GH, OPCH, RDNT, SHC, PRVA, BTSG, SGRY, WGS, and CON

Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), Privia Health Group (PRVA), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

agilon health vs.

Hims & Hers Health (NYSE:HIMS) and agilon health (NYSE:AGL) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking.

Hims & Hers Health has higher earnings, but lower revenue than agilon health. agilon health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B5.27-$23.55M$0.5464.88
agilon health$6.06B0.27-$262.60M-$0.63-6.21

In the previous week, Hims & Hers Health had 37 more articles in the media than agilon health. MarketBeat recorded 50 mentions for Hims & Hers Health and 13 mentions for agilon health. agilon health's average media sentiment score of 0.78 beat Hims & Hers Health's score of 0.64 indicating that agilon health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
21 Very Positive mention(s)
7 Positive mention(s)
12 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
agilon health
4 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health presently has a consensus price target of $36.92, indicating a potential upside of 5.36%. agilon health has a consensus price target of $4.81, indicating a potential upside of 22.80%. Given agilon health's stronger consensus rating and higher possible upside, analysts plainly believe agilon health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
agilon health
2 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11

agilon health received 12 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 44.00% of users gave agilon health an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
43
35.25%
Underperform Votes
79
64.75%
agilon healthOutperform Votes
55
44.00%
Underperform Votes
70
56.00%

Hims & Hers Health has a net margin of 8.19% compared to agilon health's net margin of -6.88%. Hims & Hers Health's return on equity of 10.97% beat agilon health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
agilon health -6.88%-47.84%-14.97%

63.5% of Hims & Hers Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 3.2% of agilon health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hims & Hers Health has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, agilon health has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500.

Summary

Hims & Hers Health beats agilon health on 11 of the 18 factors compared between the two stocks.

Get agilon health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

Metricagilon healthhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$1.62B$1.98B$5.49B$18.96B
Dividend YieldN/A7.12%5.11%4.02%
P/E Ratio-4.1615.7522.6132.97
Price / Sales0.273.79397.5127.82
Price / CashN/A9.3238.1817.52
Price / Book2.403.976.704.48
Net Income-$262.60M$87.49M$3.22B$1.02B
7 Day Performance2.49%-1.04%1.26%0.78%
1 Month Performance-3.69%-5.74%3.73%-2.56%
1 Year Performance-20.99%-26.83%15.82%4.69%

agilon health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
agilon health
1.6716 of 5 stars
$3.90
-8.6%
$4.81
+23.4%
-22.5%$1.61B$6.06B-4.14650Upcoming Earnings
Analyst Forecast
News Coverage
HIMS
Hims & Hers Health
2.3721 of 5 stars
$25.91
-4.8%
$38.25
+47.6%
+164.1%$5.76B$1.48B58.89650Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
GH
Guardant Health
3.9492 of 5 stars
$42.61
-5.2%
$49.00
+15.0%
+162.4%$5.26B$739.02M-11.971,790Analyst Forecast
News Coverage
Gap Up
OPCH
Option Care Health
3.1504 of 5 stars
$31.25
-2.4%
$33.00
+5.6%
+8.1%$5.13B$5.00B26.265,600Earnings Report
Analyst Upgrade
News Coverage
Positive News
RDNT
RadNet
4.0245 of 5 stars
$47.36
-4.9%
$69.75
+47.3%
+8.0%$3.51B$1.83B-676.478,970Positive News
SHC
Sotera Health
2.3998 of 5 stars
$10.32
-1.5%
$15.20
+47.3%
+2.7%$2.93B$1.10B41.283,000News Coverage
Gap Up
PRVA
Privia Health Group
4.1161 of 5 stars
$22.71
-4.1%
$27.00
+18.9%
+27.6%$2.76B$1.74B227.12810Upcoming Earnings
Analyst Forecast
Short Interest ↓
News Coverage
Positive News
BTSG
BrightSpring Health Services
2.5549 of 5 stars
$15.62
-5.9%
$21.67
+38.7%
+64.0%$2.73B$11.27B-60.0835,000Upcoming Earnings
News Coverage
Positive News
SGRY
Surgery Partners
3.2333 of 5 stars
$20.20
-4.8%
$34.75
+72.0%
-12.0%$2.58B$3.11B-42.0812,200News Coverage
WGS
GeneDx
2.1962 of 5 stars
$91.04
-4.6%
$72.33
-20.5%
+291.6%$2.56B$305.45M-46.451,200Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Up
CON
Concentra Group Holdings Parent
N/A$19.88
-2.5%
$28.50
+43.4%
N/A$2.53B$1.90B13.1711,000Upcoming Earnings
Positive News

Related Companies and Tools


This page (NYSE:AGL) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners